MAVS expressed by hematopoietic cells is critical for control of West Nile virus infection and pathogenesis

Journal of Virology

Volumn 90, Issue 16, 2016, Pages 7098-7108

  Zhao, Jincun ^a,b   Vijay, Rahul ^b   Zhao, Jingxian ^b   Gale, Michael ^c   Diamond, Michael S ^d   Perlman, Stanley ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MAVS; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOKINE; IPS-1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENETIC ASSOCIATION; HEMATOPOIETIC CELL; IMMUNE DYSREGULATION; IN VITRO STUDY; INFECTION CONTROL; LEUKOCYTE; MACROPHAGE; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; MICROGLIA; MORTALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS PATHOGENESIS; WEST NILE VIRUS; WILD TYPE; ANIMAL; BRAIN; C57BL MOUSE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; WEST NILE FEVER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRAIN; CELL PROLIFERATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; IMMUNITY, INNATE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84982227889     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00707-16     Document Type: Article

References (31)

1. Malone RW, Homan J, Callahan MV, Glasspool-Malone J, Damodaran L, Schneider Ade B, Zimler R, Talton J, Cobb RR, Ruzic I, Smith-Gagen J, Janies D, Wilson J. 2016. Zika virus: medical countermeasure development challenges. PLoS Negl Trop Dis 10:e0004530. http://dx.doi.org /10.1371/journal.pntd.0004530.
2. Suthar MS, Diamond MS, Gale M, Jr. 2013. West Nile virus infection and immunity. Nat Rev Microbiol 11:115-128. http://dx.doi.org/10.1038 /nrmicro2950.
3. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja MK, Diamond MS, Gale M, Jr. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6:e1000757. http://dx.doi.org/10.1371/journal.ppat .1000757.
4. Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Jr, Fruh K, Diamond MS. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog 9:e1003118. http://dx .doi.org/10.1371/journal.ppat.1003118.
5. Errett JS, Suthar MS, McMillan A, Diamond MS, Gale M, Jr. 2013. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol 87:11416-11425. http://dx.doi .org/10.1128/JVI.01488-13.
6. Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M, Jr, Diamond MS. 2010. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol 84:12125-12138. http://dx.doi.org/10.1128/JVI.01026-10.
7. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010.
8. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203: 1795-1803. http://dx.doi.org/10.1084/jem.20060792.
9. Brien JD, Lazear HM, Diamond MS. 2013. Propagation, quantification, detection, and storage of West Nile virus. Curr Protoc Microbiol 31:15D.3.1- 15D.3.18. http://dx.doi.org/10.1002/9780471729259.mc15d03s31.
10. Zhao J, Zhao J, Van Rooijen N, Perlman S. 2009. Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog 5:e1000636. http://dx .doi.org/10.1371/journal.ppat.1000636.
11. Zhao J, Zhao J, Perlman S. 2010. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol 84:9318-9325. http://dx.doi.org/10.1128/JVI.01049-10.
12. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 69:8127-8131.
13. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37:1845-1854. http://dx.doi.org/10.1002/eji.200737192.
14. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2008. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181:8568-8575. http: //dx.doi.org/10.4049/jimmunol.181.12.8568.
15. Trandem K, Zhao J, Fleming E, Perlman S. 2011. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirusinduced encephalitis. J Immunol 186:3642-3652. http://dx.doi.org/10 .4049/jimmunol.1003292.
16. + T-cell memory and prime-boost response after dendriticcell vaccination. Nat Med 11:748-756. http://dx.doi.org/10.1038/nm1257.
17. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77:13323-13334. http://dx.doi.org/10.1128/JVI.77.24.13323-13334.2003.
18. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ. 2009. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119:3266-3277. http://dx.doi.org/10.1172/JCI39387.
19. Trandem K, Anghelina D, Zhao J, Perlman S. 2010. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol 184:4391-4400. http://dx.doi.org /10.4049/jimmunol.0903918.
20. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373. http://dx.doi.org/10 .1038/nm1140.
21. Daffis S, Samuel MA, Suthar MS, Gale M, Jr, Diamond MS. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 82:10349-10358. http://dx.doi.org/10.1128/JVI.00935-08.
22. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, Garcia-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695. http://dx.doi .org/10.1038/nature12862.
23. Martinez TN, Chen X, Bandyopadhyay S, Merrill AH, Tansey MG. Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons. Mol Neurodegener 7:45. http://dx.doi.org/10.1186/1750-1326-7-45.
24. Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. 2008. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation 5:8. http://dx.doi.org/10.1186/1742-2094-5-8.
25. Tsunoda I, Fujinami RS. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673-686. http://dx.doi.org/10 .1097/00005072-199606000-00001.
26. Bennett JL, Elhofy A, Canto MC, Tani M, Ransohoff RM, Karpus WJ. CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45(high)CD11b(+) monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol 9:623-636.
27. Trujillo JA, Fleming EL, Perlman S. 2013. Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection. J Virol 87:2376-2389. http://dx.doi.org/10.1128/JVI.03089-12.
28. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell IL, King NJ. 2008. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 205:2319-2337. http://dx.doi.org /10.1084/jem.20080421.
29. Belkaid Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7:875-888. http://dx.doi.org/10.1038/nri2189.
30. Zhao J, Zhao J, Perlman S. 2014. Virus-specific regulatory T cells ameliorate encephalitis by repressing effector T cell functions from priming to effector stages. PLoS Pathog 10:e1004279. http://dx.doi.org/10.1371 /journal.ppat.1004279.
31. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Backstrom BT, Sobel RA, Wucherpfennig KW, Strom TB, Oukka M, Kuchroo VK. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13:423-431. http://dx.doi .org/10.1038/nm1564.